Work

Crosstalk Between Pro-Survival Sphingolipid Metabolism and Complement Signaling Induces Inflammasome-Mediated Tumor Metastasis

Year: 2022
Type: article
Abstract: Crosstalk between metabolic and signaling events that induce tumor metastasis remains elusive. Here, we determined how oncogenic sphingosine 1-phosphate (S1P) metabolism activates intracellular C3-complement molecules to enhance migration/metastasis. We demonstrate that increased S1P metabolism activates C3-complement processing through S1P receptor 1 (S1PR1). S1P/S1PR1-activated intracellular C3b-α′2 was associated with PPIL1 through glutamic acid 156 (E156) and aspartic acid 111 (D111) residues, resulting in NLRP3/inflammasome induction. Inactivation mutations of S1PR1 to prevent S1P signaling or mutations of C3b-α′2 to prevent its association with PPIL1 attenuated inflammasome activation and reduced lung colonization/metastasis in mice. Also, activation of the S1PR1/C3/PPIL1/NLRP3 axis was highly associated with human metastatic melanoma tissues and patient-derived xenografts (PDXs). Moreover, targeting S1PR1/C3/PPIL1/NLRP3 signaling using molecular, genetic, and/or pharmacologic tools prevented lung colonization/metastasis of B16 melanoma-derived tumors using WT and C3a-receptor1 knockout (C3aR1-/-) mice. Overall, these data provide novel strategies for the treatment of high-grade/metastatic tumors by targeting the S1PR1/C3/inflammasome axis.
Source: Cell Reports
Language: English
Open Access status: gold
Estimated APC paid: $5,200
OpenAlex ID: W4310860992
FWCI: 1.729
Cites: 68
Cited by: 32
Related to: 10